Sang Hak Lee: Clinical Trials

1 trial sponsored by Sang Hak Lee, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1

Follow Sang Hak Lee: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Atorvastatin 10mg, fenofibric acid 135mg, atorvastatin 20mg - Mixed Hyperlipidemia
Not applicableUnknownSang Hak Lee1942013-07-012013-11-04

Conditions studied

Hyperlipidemias (1)  ·  Hyperlipoproteinemia Type II (1)

Interventions

Atorvastatin (1)  ·  fenofibric acid (1)

Countries

South Korea (1)

Top investigators

Sang-Hak Lee, PhD (1)

Results publications

PMID 15247520, PMID 17520105, PMID 18650989, PMID 18996523, PMID 19081418, PMID 19195513, PMID 20110022, PMID 20816118, PMID 20934572, PMID 22592524